Nakanishi Inc.

7716.T
Medical Instruments & Supplies
2026/03/03 Updated
Market Cap: $1.4B (¥224.2B)
Stock Price: $17.17 (¥2,700)
Exchange Rate: 1 USD = ¥157.23

Notice Regarding the Status of Treasury Stock Acquisition (Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)

From February 13 to February 28, 2026, Nakanishi Inc. did not acquire any treasury stock; the number of shares acquired was 0 shares, and the acquisition cost was 0 yen.

Importance:
Page Updated: March 2, 2026
IR Disclosure Date: March 2, 2026

Key Figures

  • Maximum Number of Shares to be Acquired: 1,500,000 shares (1.81% of total issued shares)
  • Maximum Acquisition Cost: 2,500,000,000 yen
  • Acquisition Period: From February 13, 2026 to December 30, 2026

AI要約

Overview of Capital Policy

At the Board of Directors meeting held on February 12, 2026, Nakanishi Inc. resolved to acquire treasury stock in accordance with Article 165, Paragraph 3 of the Companies Act. The maximum acquisition limit is set at 1,500,000 shares, with an acquisition cost ceiling of 2,500,000,000 yen, and the acquisition period spans from February 13, 2026 to December 30, 2026. However, during the period from February 13 to February 28, 2026, no treasury stock was acquired; the number of shares acquired was 0 shares, and the acquisition cost was 0 yen.

Impact on Shareholders and Future Outlook

Since no treasury stock has been acquired to date, there has been no change in the number of outstanding shares or shareholder composition. It is necessary to continue monitoring the status of treasury stock acquisition during the remaining acquisition period. By setting the acquisition limit, the company maintains flexibility in capital policy while retaining the possibility of treasury stock acquisition as part of shareholder returns.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.